APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 3mg capsule bottle
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
29-11-2017
अनुरोध भेजा।
सक्रिय संघटक:
rivastigmine hydrogen tartrate, Quantity: 4.8 mg
थमां उपलब्ध:
Arrotex Pharmaceuticals Pty Ltd
INN (इंटरनेशनल नाम):
rivastigmine hydrogen tartrate
फार्मास्यूटिकल फॉर्म:
Capsule
रचना:
Excipient Ingredients: titanium dioxide; microcrystalline cellulose; Gelatin; maize starch; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide
प्रशासन का मार्ग:
Oral
पैकेज में यूनिट:
56, 500, 100
प्रिस्क्रिप्शन प्रकार:
(S4) Prescription Only Medicine
चिकित्सीय संकेत:
Rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the Alzheimer's type
उत्पाद समीक्षा:
Visual Identification: Hard gelatine calsule with orange, opaque body and orange opaque cap. Imprinted "APO R3" in black ink, white to off white fill.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
प्राधिकरण का दर्जा:
Registered
प्राधिकरण की तारीख:
2010-07-27
